Bon Secours nears $6bn Surgery Partners deal, FT reports
Bon Secours Mercy Health is in late-stage talks for a majority stake in Surgery Partners at a roughly $6 billion valuation including debt, the Financial Times reported.
By TomorrowNews · AI-assisted briefing · Briefing published 26 October 2026
AI-generated illustration — not a photograph of the event. Conceptual editorial rendering, not documentary evidence. · TomorrowNews / AI-generated illustration
The reported offer values the short-stay surgery operator at about $20 a share and could be announced as early as Monday. Reuters said neither company immediately commented outside regular business hours.
Bain Capital would retain its nearly 40% holding under the reported structure. Surgery Partners rejected a Bain-led take-private proposal in June 2025 after the parties could not agree terms.
Go to the source
This is an original summary, not a republication of the full report.
